Today is #DNADay marking the discovery of the double helix in 1953!
It's also an opportunity to marvel at how far we have come since the discovery over seventy years ago #GenomicMedicine #Innovation
Brush up on your genomics knowledge here: genomicseducation.hee.nhs.uk
Intellia Therapeutics $NTLA to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024. #Genomicmedicine biomediahub.com/intellia-thera…
#NationalDNADay commemorates the successful completion of the Human #Genome Project in 2003 and the discovery of DNA's double helix in 1953. #Genomics #GenomicMedicine
Today is #DNADay marking the discovery of the double helix in 1953!
It's also an opportunity to marvel at how far we've come since the discovery over seventy years ago.
#GenomicMedicine #ThinkGenomics #TeamGene
Clive Glover, our Vice President of Viral Vectors, is one of several industry experts featured in this story about how to accelerate the development of AAV based gene therapies. #Genetherapies #Genomicmedicine #Advancedtherapies genengnews.com/topics/transla…
Clive Glover, our Vice President of Viral Vectors, is one of several industry experts featured in this story about how to accelerate the development of AAV based gene therapies. #Genetherapies #Genomicmedicine #Advancedtherapies genengnews.com/topics/transla…
Research reveals HLA polymorphisms' significant impact on Helicobacter pylori-related gastric cancer risk, offering new insights into disease susceptibility. #GenomicMedicine #HLA #CancerRisk
Clive Glover, our Vice President of Viral Vectors, is one of several industry experts featured in this story about how to accelerate the development of AAV based gene therapies. #Genetherapies #Genomicmedicine #Advancedtherapies genengnews.com/topics/transla…
Clive Glover, our Vice President of Viral Vectors, is one of several industry experts featured in this story about how to accelerate the development of AAV based gene therapies. #Genetherapies #Genomicmedicine #Advancedtherapies genengnews.com/topics/transla…
This #DNADay 24 , we're reminding our readers how GGMC advances #genomicmedicine globally, especially in Lower-Middle Income Countries. Your continued support means ensuring ALL people have access.
Learn how your donation can help:
globalgenomics.org/donate/
#DNADay #Genomics
The CGP team was delighted to participate at this year’s McGill Human Genetics Conference, “Genomic Medicine for All: The Gap Between Research and Clinical Practice,” which focused on the impacts of translational medicine and research in Canada.
#GenomicMedicine #Genomics
Thank you to BIOS for inviting Replay to participate in your podcast. We enjoyed the discussion around Replay’s origins and the Company’s potential future as a leader in genomic medicine.
youtube.com/watch?v=To6u4L…
#genomicMedicine #genomeWriting #Oncology #Biotech
Today is also an opportunity to marvel at how far we have come since the discovery over seventy years ago #GenomicMedicine #Innovation
It's an opportunity to marvel at how far we have come since the discovery over seventy years ago #GenomicMedicine #Innovation
Follow us and our fellow #GMS partners across the UK to learn more about the power of #GenomicMedicine North East & Yorkshire Genomics NWGMSA NHS Central and South Genomics NHS South East Genomic Medicine Service NHS East Genomics North Thames Genomic Medicine Service
Follow us and our fellow #GMS partners across the UK to learn more about the power of #GenomicMedicine North East & Yorkshire Genomics NWGMSA NHS Central and South Genomics NHS South East Genomic Medicine Service NHS East Genomics North Thames Genomic Medicine Service